Long-Term Treatment With Apremilast in Hidradenitis Suppurativa: A 2-Year Follow-Up of Initial Responders

    Pim Aarts, Allard R.J.V. Vossen, Hessel H. van der Zee, Errol P. Prens, Kelsey R. van Straalen
    Studysummary This study suggests that apremilast shows prolonged efficacy for up to 2 years in hidradenitis suppurativa patients who initially responded to the treatment, although further verification in a larger cohort is needed.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community โ†’